Hear the latest health care trends from Prime’s 2025 Specialty Summit - Prime Therapeutics
Hear the latest health care trends from Prime’s 2025 Specialty Summit
In the latest episode of the “Pharmacy Friends” podcast, learn the latest insights on legislative trends, cutting-edge drug therapies and more from the 22nd annual event
Each year, Prime Therapeutics (Prime) brings together more than 600 clients and health care industry experts to New York for Specialty Summit. Built around the theme of “Powering Change,” the event is an opportunity for Prime experts to share the latest in medical pharmacy trends, biosimilar strategy and innovative solutions to improve access to specialty therapies.
Prime Therapeutics made an appearance in Times Square in New York City as a part of Specialty Summit 2025.
Jordan Almazan, senior director of clinical strategy and specialty solutions at Prime, on the importance of Prime’s member and patient experience and a recap of what Specialty Summit is all about.
Watch the segment »
Steve Cutts, senior vice president of specialty and clinical solutions at Prime, on Prime’s specialty drug expertise and how to drive quality of care, access and affordability; and how Prime’s transparent, innovative operating model puts the patient at the center of care.
Watch the segment »
George Van Antwerp, senior vice president of product innovation, on how creativity and innovation propel growth, the impact of the clinical and regulatory landscape on the patient journey and how he unlocks the talent of the Prime team.
Watch the segment »
Dinesh Kandanchatha, senior vice president and chief information and officer, on how Prime uses technology and artificial intelligence (AI) to advance care for patients, streamline processes and enable smarter decision-making that can lead to a healthier, tech-enabled future.
Watch the segment »
Roxanne Schwans, senior vice president of supply chain, on the evolution of biosimilars, Prime’s biosimilar strategy and what thatmeans for health plans.
Watch the segment »
Brian MacDonald, senior director of clinical strategy and programs, on the specialty therapy pipeline.
Watch the segment »
David Root, vice president of government affairs, and Caitlin Berry, government affairs policy advisor, on the latest regulatory and policy trends and their impact on the specialty drug and health care space.
Watch the segment »
For additional insights from Specialty Summit, watch selected clips from the events on Prime's YouTube channel. And to listen to additional episodes of the “Pharmacy Friends” podcast, at PrimeTherapeutics.com/Listen.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.